William Blair & Company
GWPH

William Blair & Company’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

William Blair & Company’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,704
Closed -$207K – 1687
2017
Q1 		$207K Buy
+1,704
New +$209K ﹤0.01% 1215

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

William Blair & Company's GWPH Position: Q2 2017 in Review

William Blair & Company sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2017, closing a stake of 1,704 shares — an estimated $207K sold.

William Blair & Company first reported a position in GWPH in Q1 2017 and held it in 1 quarter. The position peaked at $207K in Q1 2017. 170 funds tracked by Wall St. Rank hold GWPH as of Q2 2017.

  • William Blair & Company reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2017 after selling out during the quarter.
  • William Blair & Company sold 1,704 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2017, an estimated $207K.
  • William Blair & Company first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2017 and held it in 1 quarter.
  • William Blair & Company's GW Pharmaceuticals Plc American Depositary Shares position peaked at $207K in Q1 2017.
  • 170 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2017.

Based on William Blair & Company's 13F filing for Q2 2017, filed 4 Aug 2017.